logo

Thomas Kosten, MD

Thomas Kosten, MD

Neurology Houston, TX

Professor, Psychiatry, Baylor College of Medicine

Office Address

Office Map
  • 2002 Holcombe Blvd
    Va Bldg 110, Room 229
    Houston, TX 77030
    Phone: (713) 794-7032

Dr. Kosten's Clinical Specialties & Interests

  • Neurology: Addiction Medicine

Dr. Kosten's Faculty Appointments & Work History

  • Professor of Behavioral Science and EpidemiologyMD Anderson Cancer Center
    Houston, TX

Dr. Kosten's Education & Medical Training

  • Yale-New Haven HospitalYale-New Haven HospitalResidency, Psychiatry
  • Yale University School of MedicineYale University School of MedicineResidency, Psychiatry
  • Yale-New Haven HospitalYale-New Haven HospitalResidency, Psychiatry
  • Cornell Univ Med CollWeill Cornell Medical College of Cornell UniversityMedical School

Dr. Kosten's Certifications & Licensure

  • TX State Medical LicenseTX State Medical License2007 - 2014
  • CT State Medical LicenseCT State Medical License1979 - 2015
  • American Board of Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyPsychiatry
  • American Board of Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyAddiction Psychiatry

Dr. Kosten's Awards, Honors, & Recognition

  • Marquis Whos WhoWhos Who in Medicine and HealthcareMarquis Whos Who

Dr. Kosten's Clinical Trials

Dr. Kosten's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Human Methamphetamine Vaccine:  Translational Avante Garde Award
    Human Methamphetamine Vaccine: Translational Avante Garde AwardNational Institute On Drug Abuse
    2011 - 2011
  • Methadone Studies
    Methadone StudiesNational Institute On Drug Abuse
    2009 - 2011
  • Stimulant Pharmacotherapy: Noradrenergic Targets
    Stimulant Pharmacotherapy: Noradrenergic TargetsNational Institute On Drug Abuse
    2009 - 2011
  • Developing Immunotherapeutics For Methamphetamine Abuse
    Developing Immunotherapeutics For Methamphetamine AbuseNational Institute On Drug Abuse
    2009 - 2010
  • Clinical Methods Core
    Clinical Methods CoreNational Institute On Drug Abuse
    2009 - 2011
  • Multisite Controlled Trial Of Cocaine Vaccine (1of 6) LEAD Site/ Houston Treatmen
    Multisite Controlled Trial Of Cocaine Vaccine (1of 6) LEAD Site/ Houston TreatmenNational Institute On Drug Abuse
    2008 - 2012
  • Pharmacotherapies Of Cocaine Addiction In Humans
    Pharmacotherapies Of Cocaine Addiction In HumansNational Institute On Drug Abuse
    2007 - 2007
  • Administrative And Scientific Core
    Administrative And Scientific CoreNational Institute On Drug Abuse
    2007 - 2008
  • Tropisetron With Risperidone For Schizophrenia
    Tropisetron With Risperidone For SchizophreniaNational Institute Of Mental Health
    2007 - 2009
  • Cocaine Pharmacotherapy Targeting Dopamine &Gaba
    Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse
    2006 - 2008
  • Comorbidity In  Cocaine And Opioid Pharmacotherapy
    Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
    2006 - 2010
  • Heroin Addiction Treatment: Naltrexone And Lofexidine
    Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse
    2006 - 2007
  • Comorbidity In  Cocaine And Opioid Pharmacotherapy
    Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
    2005 - 2005
  • Kappa Opioid Antagonist For Cocaine Addiction
    Kappa Opioid Antagonist For Cocaine AddictionNational Institute On Drug Abuse
    2005 - 2011
  • Heroin Addiction Treatment: Naltrexone And Lofexidine
    Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse
    2004 - 2005
  • Cocaine Pharmacotherapy Targeting Dopamine &Gaba
    Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse
    2004 - 2005
  • Scientific And Administrative Core
    Scientific And Administrative CoreNational Institute On Drug Abuse
    2004 - 2004
  • FMRI Of Gender And Stress Response In Cocaine Dependence
    FMRI Of Gender And Stress Response In Cocaine DependenceNational Institute On Drug Abuse
    2002 - 2002
  • Cocaine Vaccine For Methadone Maintained Patients
    Cocaine Vaccine For Methadone Maintained PatientsNational Institute On Drug Abuse
    2002 - 2004
  • Pharmacotherapy For Opioid And Cocaine Dependence
    Pharmacotherapy For Opioid And Cocaine DependenceNational Institute On Drug Abuse
    2001 - 2004
  • Immunological Agents For Cocaine Abuse
    Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse
    2000 - 2002
  • Comorbidity In Cocaine And Opioid Pharmacotherapy
    Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
    2000 - 2004
  • Active Immunization To Develop Antibodies To Cocaine
    Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse
    2000 - 2002
  • 11th - 15th Annual Meetings And Symposia
    11th - 15th Annual Meetings And SymposiaNational Institute On Drug Abuse
    2000 - 2001
  • Therapeutic Cocaine Vaccine
    Therapeutic Cocaine VaccineNational Institute On Drug Abuse
    2000 - 2002
  • Core--Medication Development Research Center
    Core--Medication Development Research CenterNational Institute On Drug Abuse
    1999 - 2002
  • Clopidogrel &Isradipine For Brian Perfusion Defects In Cocaine Abusers
    Clopidogrel &Isradipine For Brian Perfusion Defects In Cocaine AbusersNational Institute On Drug Abuse
    1999 - 2002
  • Cocaine Pharmacotherapies For Comorbid Populations
    Cocaine Pharmacotherapies For Comorbid PopulationsNational Institute On Drug Abuse
    1999 - 2003
  • 9th/13th Annual Meeting And Symposium
    9th/13th Annual Meeting And SymposiumNational Institute On Drug Abuse
    1998 - 1999
  • Immunological Agents For Cocaine Abuse
    Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse
    1997 - 1998
  • Active Immunization To Develop Antibodies To Cocaine
    Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse
    1997 - 1998
  • Cocaine Discrimination In Humans--Effects Of Dopaminergic Agents
    Cocaine Discrimination In Humans--Effects Of Dopaminergic AgentsNational Institute On Drug Abuse
    1996 - 1997
  • Non-Opioid Neurobiology Of Opioid Dependence
    Non-Opioid Neurobiology Of Opioid DependenceNational Institute On Drug Abuse
    1996 - 1997
  • Core--Core
    Core--CoreNational Institute On Drug Abuse
    1996 - 1998
  • Agonist To Antagonist--New Approaches
    Agonist To Antagonist--New ApproachesNational Institute On Drug Abuse
    1994 - 1995
  • Reducing AIDS Risks
    Reducing AIDS RisksNational Institute On Drug Abuse
    1994 - 1994
  • Yale Medications Development Research Center
    Yale Medications Development Research CenterNational Institute On Drug Abuse
    1994 - 1998
  • Small Instrumentation Grant
    Small Instrumentation GrantNational Institute On Drug Abuse
    1993 - 1993
  • Matching Methadone Patients To Psychosocial Treatment
    Matching Methadone Patients To Psychosocial TreatmentNational Institute On Drug Abuse
    1993 - 1994
  • The Yale University Substance Abuse Research Center
    The Yale University Substance Abuse Research CenterNational Institute On Drug Abuse
    1991 - 1991
  • Clinical Research Center For Opioid And Cocaine Abuse
    Clinical Research Center For Opioid And Cocaine AbuseNational Institute On Drug Abuse
    1991 - 1999
  • Treatment Research Unit--Reducing AIDS Risks
    Treatment Research Unit--Reducing AIDS RisksNational Institute On Drug Abuse
    1989 - 1993
  • Buprenorphine Maintenance For Opioid Addicts
    Buprenorphine Maintenance For Opioid AddictsNational Institute On Drug Abuse
    1988 - 2000
  • Agonist To Antagonist:  New Approaches
    Agonist To Antagonist: New ApproachesNational Institute On Drug Abuse
    1987 - 1993
  • Pharmacotherapy Of IV Cocaine Use In Methadone Patients
    Pharmacotherapy Of IV Cocaine Use In Methadone PatientsNational Institute On Drug Abuse
    1987 - 1989

Dr. Kosten's Professional Memberships


Physicians, view Dr. Kosten's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV